Indo Amines is a chemical manufacturer built on a single, recurring idea: take a family of molecules - amines - and stretch that chemistry into hundreds of different products for industries as far apart as pharmaceuticals, road-building, and perfumes. The company started in 1994 with two plants making fine and specialty chemicals, and over three decades it has grown by acquiring and merging other chemical makers, adding new reactions and synthesis routes through its own R&D, and pushing exports to more than 70 countries. The approach that explains everything else is vertical integration from in-house process chemistry - the company develops its own ways to make molecules, then scales them across five factories, selling the output in bulk to other businesses worldwide.
Business segments
A single integrated chemicals engine - one manufacturing platform producing over 500 fine, specialty and performance chemicals, sold in bulk to industrial customers across more than 70 countries - where the same factories, R&D and supply chain serve every end-market.
1. Fine, specialty and performance chemicals: a single integrated manufacturing engine
The company makes over 500 different chemicals across five factories, using chemistry developed in its own labs, and sells them in bulk to industrial buyers in pharmaceuticals, agrochemicals, paints, rubber, fragrances and a dozen other industries - one set of plants and one supply chain serves them all.
- One business segment, many end-uses - the company operates in a single business segment: manufacturing of chemicals. Those chemicals go into agrochemicals, pharmaceuticals, high-performance polymers, paints, pigments, printing inks, rubber chemicals, additives, surfactants, dyes, flavours and fragrances, and home and personal care products, so a downturn in any one industry does not sink the whole business.
- In-house chemistry is the foundation - a DSIR-approved R&D unit staffed with experienced scientists develops the synthesis routes and chemical reactions that the factories then scale up, which is how the company keeps its costs competitive while making molecules that meet international quality standards.
- Five factories, 110,000 tonnes of annual capacity - the company runs five manufacturing sites across Maharashtra and Gujarat (Baroda, Dhule, Mahad, Badlapur and Dombivli), with ten factory units spread across them and a total installed capacity of 110,000 metric tonnes per year. Each site is equipped for large-scale production, and the company has upgraded several units to zero liquid discharge (ZLD) standards.
- Exports are more than half the business - over 50% of production is exported, reaching more than 70 countries across Asia-Pacific, North America, Europe, the Middle East, Africa and Latin America. The company set up marketing bases in Europe and South East Asia in 2010, opened an Americas office in 2015, and obtained REACH permission to sell into the European market.
- Bulk sales to business customers - the company generates revenue through one-time product sales in bulk or tonnage quantities to B2B customers; it is not a branded consumer-goods business but a supplier of industrial ingredients. The product range spans amines, amides, isocyanurates and glycidyl ethers, with a new line of morpholine and derivatives launched in 2025.
Group structure and partners
The company has grown by absorbing other chemical manufacturers through mergers, while its international marketing subsidiaries and a recently diluted associate extend its reach and capacity.
- A history of consolidation through mergers - the company has merged with or acquired several chemical manufacturers over the years, including Key Organics (agrochemicals, 2014), Classic Oil (chemicals, 2017), Core Chemicals (agrochemicals), Versatile Chemicals (manufacturing division, 2012), and Flame Pharmaceuticals and Sheeraj Chemicals (2006). Most recently, it received NCLT approval to merge with Pious Engineering Private Ltd in 2024, adding engineering and fabrication capabilities.
- International marketing arms - the company has historically maintained subsidiaries in China, Malaysia, the United States and Europe to support its export push, though their current operational status varies across filings.
- A diluted associate in specialty chemicals - Indo Speciality Chemicals Private Limited (formerly Ashok Surfactants) ceased to be a subsidiary in March 2026 after the company chose not to participate in a rights issue, reducing its stake from roughly 51% to 39% and making it an associate rather than a consolidated entity. That associate holds environmental clearance for expanding synthetic organic chemical capacity at its Mahad plant.
- Promoter-led, publicly listed - the board includes three members of the Palkar family as Managing Director, Whole-time Director and Joint Managing Director, and the company’s shares trade on both the BSE and the National Stock Exchange of India.